In this work, we propose a novel double-quenching electrochemical
luminescence (ECL) strategy; this strategy is based on the double-quenching
effect of Ru(bpy)3
2+-functionalized three-dimensional
(3D) metal–organic framework (MOF) by MnO2/PDA.
An ECL immunosensor for ultrasensitive detection of alpha-fetoprotein
(AFP) has been designed. TMU-3 with a rich mesoporous structure can
be used to encapsulate Ru(bpy)3
2+, which can
effectively reduce the leakage of Ru(bpy)3
2+. Moreover, the ultraviolet–visible (UV–vis) absorption
spectrum of the lamellar MnO2/PDA nanomaterials with a
nanometer scale of about 1 μm overlaps with the ECL emission
spectrum of the porous bamboo leaf-like Ru(bpy)3
2+@TMU-3 with a nanometer scale of about 1 μm. Thus, an ECL resonance
energy transfer (ECL-RET) mechanism between Ru(bpy)3
2+@TMU-3 (donor) and MnO2/PDA (recipient) is formed.
In this way, an ECL immunosensor with a dual-quenching strategy for
ECL signal is developed. In order to test the practicability of this
method in clinical analysis, the detection target marker AFP content
ranged from 0.01 pg/mL to 5 ng/mL and the detection limit was set
to 10.7 fg/mL. In summary, this work demonstrates the detection and
application of a signal-quenched ECL immunosensor and ECL immunoassay
based on a luminescence-functionalized MOF system for biomarker detection.
It indicates a great prospect in the analysis of other biomarkers
and clinical analysis.